1. Medtech Insight

Vital Images and iCAD form colon CAD (computer-aided detection) deal:

Vital Images is to integrate iCAD's Second Look CT colon computer-aided detection (CAD) application into its flagship imaging software for evaluating CT and MR image data, Vitrea 2. In a non-exclusive deal between the two firms, Minneapolis, Minnesota-based Vital Images will distribute the new CAD option, pending regulatory review from the US FDA. CAD is a software technology designed to identify suspicious areas during CT screening exams, helping physicians find polyps that could lead to colon cancer.

Vital Images is to integrate iCAD's Second Look CT colon computer-aided detection (CAD) application into its flagship imaging software for evaluating CT and MR image data, Vitrea 2. In a non-exclusive deal between the two firms, Minneapolis, Minnesota-based Vital Images will distribute the new CAD option, pending regulatory review from the US FDA. CAD is a software technology designed to identify suspicious areas during CT screening exams, helping physicians find polyps that could lead to colon cancer.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight

Ochsner Surgeon In ‘The Big Easy’ Eases Patient’s Pain With Skill And Virtual Reality

 
• By Brian Bossetta

A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.

Execs On The Move: June 30–July 4, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

FDA Commissioner’s Voucher Program Should Include Devices, Transplant Technology Firm Says

 
• By Elizabeth Orr

The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.